• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮花生贴片装置治疗花生过敏。

Epicutaneous peanut patch device for the treatment of peanut allergy.

机构信息

a Department of Allergy and Immunology , Centre Hospitalier Universitaire Sainte-Justine , Montreal , QC , Canada.

b Department of Allergy and Immunology , Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame , Montreal , QC , Canada.

出版信息

Expert Rev Clin Immunol. 2019 May;15(5):449-460. doi: 10.1080/1744666X.2019.1593138. Epub 2019 Mar 27.

DOI:10.1080/1744666X.2019.1593138
PMID:30864861
Abstract

Food allergy prevalence has increased in recent decades, which has mobilized efforts to develop treatment alternatives. Epicutaneous immunotherapy (EPIT) is a novel method that involves transdermal administration of peanut allergen with the objective to induce tolerance. Recent clinical trials have shown its efficacy at increasing the eliciting dose in children with a favorable safety profile. Areas covered: This review covers the proposed mechanism of action of EPIT in murine models and humans, efficacy and safety data from clinical trials with peanut EPIT, and a discussion on its potential role in the future management of peanut allergy. Expert opinion: With the recent completion of pivotal trials for peanut EPIT and upcoming marketing, the main question for clinicians and food allergic patients is how to define its role in the management of peanut allergy and how it compares to oral immunotherapy (OIT). Like OIT, EPIT seems to promote immunological tolerance over time. However, EPIT could lack the rapid mast-cell desensitization induced by the progressive intake of food in OIT, which explains differences in short-term outcomes and safety profiles. Head-to-head and long-term comparison of real-life efficacy with regards to sustained unresponsiveness will help define its place in the food allergy arsenal.

摘要

食物过敏的患病率在近几十年有所增加,这促使人们努力开发治疗的替代方法。经皮免疫疗法(EPIT)是一种新的方法,通过透皮给予花生过敏原,目的是诱导耐受。最近的临床试验表明,它在增加儿童的过敏原剂量方面具有疗效,且安全性良好。

涵盖的领域

本文综述了 EPIT 在小鼠模型和人体中的作用机制、花生 EPIT 的临床试验的疗效和安全性数据,并讨论了其在未来花生过敏管理中的潜在作用。

专家意见

随着花生 EPIT 的关键试验的最近完成和即将上市,临床医生和食物过敏患者的主要问题是如何定义其在花生过敏管理中的作用,以及它与口服免疫疗法(OIT)相比如何。与 OIT 一样,EPIT 似乎随着时间的推移促进免疫耐受。然而,EPIT 可能缺乏 OIT 中逐渐摄入食物引起的快速肥大细胞脱敏,这解释了短期结果和安全性特征的差异。关于无反应的持续时间,进行 EPIT 与 OIT 的真实疗效的头对头和长期比较将有助于确定其在食物过敏武器库中的地位。

相似文献

1
Epicutaneous peanut patch device for the treatment of peanut allergy.经皮花生贴片装置治疗花生过敏。
Expert Rev Clin Immunol. 2019 May;15(5):449-460. doi: 10.1080/1744666X.2019.1593138. Epub 2019 Mar 27.
2
Immunotherapy approaches for peanut allergy.花生过敏的免疫疗法
Expert Rev Clin Immunol. 2020 Feb;16(2):167-174. doi: 10.1080/1744666X.2019.1708192. Epub 2020 Jan 12.
3
Food allergy immunotherapy: Oral immunotherapy and epicutaneous immunotherapy.食物过敏免疫疗法:口服免疫疗法和经皮免疫疗法。
Allergy. 2020 Jun;75(6):1337-1346. doi: 10.1111/all.14220. Epub 2020 Feb 28.
4
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.儿童变应原皮内免疫治疗的疗效和安全性的长期、开放性扩展研究:PEOPLE 研究 3 年结果。
J Allergy Clin Immunol. 2020 Oct;146(4):863-874. doi: 10.1016/j.jaci.2020.06.028. Epub 2020 Jul 10.
5
Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy.DBV712(花生贴片)经皮免疫治疗花生过敏的安全性和有效性。
Expert Rev Clin Immunol. 2024 Jun;20(6):623-633. doi: 10.1080/1744666X.2024.2315221. Epub 2024 Feb 14.
6
Advances in the management of peanut allergy (oral immunotherapy and epicutaneous immunotherapy).花生过敏管理的新进展(口服免疫治疗和经皮免疫治疗)。
Allergy Asthma Proc. 2020 Jan 1;41(1):5-9. doi: 10.2500/aap.2020.41.190011.
7
Update on peanut allergy: Prevention and immunotherapy.花生过敏的最新进展:预防与免疫疗法。
Allergy Asthma Proc. 2019 Jan 1;40(1):14-20. doi: 10.2500/aap.2019.40.4190.
8
Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.特定的经皮免疫治疗可预防小鼠模型中新过敏原的致敏。
J Allergy Clin Immunol. 2015 Jun;135(6):1546-57.e4. doi: 10.1016/j.jaci.2014.11.028. Epub 2015 Jan 9.
9
Immunotherapy for Food Allergy: Are We There Yet?食物过敏的免疫疗法:我们做到了吗?
J Allergy Clin Immunol Pract. 2017 Mar-Apr;5(2):250-272. doi: 10.1016/j.jaip.2016.12.004.
10
Safety and efficacy of epicutaneous immunotherapy for food allergy.经皮免疫治疗食物过敏的安全性和有效性。
Pediatr Allergy Immunol. 2018 Jun;29(4):341-349. doi: 10.1111/pai.12869. Epub 2018 Mar 1.

引用本文的文献

1
Innovative delivery systems for epicutaneous immunotherapy.经皮免疫治疗的创新给药系统。
Front Immunol. 2023 Aug 22;14:1238022. doi: 10.3389/fimmu.2023.1238022. eCollection 2023.
2
Solid-in-Oil Nanodispersions for Transcutaneous Immunotherapy of Japanese Cedar Pollinosis.用于日本雪松花粉症经皮免疫治疗的油包固纳米分散体
Pharmaceutics. 2020 Mar 7;12(3):240. doi: 10.3390/pharmaceutics12030240.